Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy

Am J Respir Crit Care Med. 2023 Jul 1;208(1):103-105. doi: 10.1164/rccm.202303-0380LE.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminophenols / therapeutic use
  • Benzodioxoles / therapeutic use
  • Child
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / genetics
  • Humans
  • Intracranial Pressure
  • Mutation

Substances

  • elexacaftor
  • ivacaftor
  • tezacaftor
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Aminophenols
  • Benzodioxoles